NASDAQ:RMTI - Rockwell Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$5.94 0.00 (0.00 %)
(As of 05/25/2018 07:23 AM ET)
Previous Close$5.94
Today's Range$5.94 - $5.94
52-Week Range$4.84 - $8.70
Volume7,760 shs
Average Volume188,764 shs
Market Capitalization$307.50 million
P/E Ratio-11.65
Dividend YieldN/A
Beta2.18

About Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical logoRockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company's target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:RMTI
CUSIP77437410
Phone248-960-9009

Debt

Debt-to-Equity RatioN/A
Current Ratio5.25
Quick Ratio4.23

Price-To-Earnings

Trailing P/E Ratio-11.65
Forward P/E Ratio-15.63
P/E GrowthN/A

Sales & Book Value

Annual Sales$57.30 million
Price / Sales5.37
Cash FlowN/A
Price / CashN/A
Book Value$0.53 per share
Price / Book11.21

Profitability

EPS (Most Recent Fiscal Year)($0.51)
Net Income$-25,920,000.00
Net Margins-48.06%
Return on Equity-76.49%
Return on Assets-45.06%

Miscellaneous

Employees300
Outstanding Shares51,770,000

Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How were Rockwell Medical's earnings last quarter?

Rockwell Medical Inc (NASDAQ:RMTI) issued its earnings results on Thursday, May, 10th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.14) by $0.01. The company earned $14.95 million during the quarter. Rockwell Medical had a negative net margin of 48.06% and a negative return on equity of 76.49%. View Rockwell Medical's Earnings History.

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Rockwell Medical.

What price target have analysts set for RMTI?

1 brokers have issued 1-year price targets for Rockwell Medical's stock. Their forecasts range from $11.00 to $11.00. On average, they anticipate Rockwell Medical's stock price to reach $11.00 in the next twelve months. View Analyst Ratings for Rockwell Medical.

Who are some of Rockwell Medical's key competitors?

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the folowing people:
  • Mr. Robert L. Chioini, Founder & CEO (Age 53)
  • Mr. Thomas E. Klema CPA, MBA, Chief Financial Officer, VP of Fin., Treasurer and Sec. (Age 64)
  • Dr. Ajay Gupta M.D., Chief Scientific Officer and Member of Scientific Advisory Board (Age 60)
  • Dr. Raymond Dennis Pratt M.D., FACP, Chief Medical Officer (Age 67)

Has Rockwell Medical been receiving favorable news coverage?

Headlines about RMTI stock have been trending somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Rockwell Medical earned a daily sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the company an impact score of 45.89 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include RICHMOND BROTHERS, INC. (10.80%) and Schwab Charles Investment Management Inc. (0.19%). Company insiders that own Rockwell Medical stock include David S Richmond and Kenneth L Holt. View Institutional Ownership Trends for Rockwell Medical.

Which major investors are buying Rockwell Medical stock?

RMTI stock was acquired by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc.. View Insider Buying and Selling for Rockwell Medical.

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $5.94.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $307.50 million and generates $57.30 million in revenue each year. The company earns $-25,920,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis. Rockwell Medical employs 300 workers across the globe.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 30142 S WIXOM RD, WIXOM MI, 48393. The company can be reached via phone at 248-960-9009 or via email at [email protected]


MarketBeat Community Rating for Rockwell Medical (RMTI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  196 (Vote Outperform)
Underperform Votes:  222 (Vote Underperform)
Total Votes:  418
MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Rockwell Medical (NASDAQ:RMTI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Rockwell Medical in the last 12 months. Their average twelve-month price target is $11.00, suggesting that the stock has a possible upside of 85.19%. The high price target for RMTI is $11.00 and the low price target for RMTI is $11.00. There are currently 1 strong buy rating for the stock, resulting in a consensus rating of "Strong Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: Strong BuyStrong BuyStrong BuyStrong Buy
Consensus Rating Score: 4.004.004.004.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $11.00$11.00$11.00$11.00
Price Target Upside: 85.19% upside76.28% upside76.28% upside76.28% upside

Rockwell Medical (NASDAQ:RMTI) Consensus Price Target History

Price Target History for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ:RMTI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/14/2017Ifs SecuritiesInitiated CoverageStrong-Buy$11.00MediumView Rating Details
11/9/2016BTIG ResearchReiterated RatingBuy$12.00N/AView Rating Details
11/8/2016Bank of AmericaDowngradeNeutral ➝ Underperform$9.00 ➝ $5.00N/AView Rating Details
(Data available from 5/25/2016 forward)

Earnings

Rockwell Medical (NASDAQ:RMTI) Earnings History and Estimates Chart

Earnings by Quarter for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ:RMTI) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.38 EPS
Next Year EPS Consensus Estimate: $0.04 EPS

Rockwell Medical (NASDAQ RMTI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/7/2018($0.15)N/AView Earnings Details
5/10/2018Q1 2018($0.14)($0.13)$14.95 millionViewN/AView Earnings Details
3/15/2018Q4 2017($0.13)($0.18)$13.20 million$14.84 millionViewListenView Earnings Details
11/8/2017Q3 2017($0.10)($0.0960)$13.33 million$14.63 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.10)($0.14)$13.05 million$13.24 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.09)($0.09)$12.66 million$14.60 millionViewListenView Earnings Details
3/15/2017Q4 2016($0.09)($0.10)$15.45 million$13.39 millionViewN/AView Earnings Details
11/7/2016Q3($0.10)($0.09)$15.40 million$12.81 millionViewListenView Earnings Details
8/8/2016Q2($0.10)($0.11)$13.86 million$12.50 millionViewN/AView Earnings Details
5/10/2016Q1($0.08)($0.10)$15.25 million$13.63 millionViewListenView Earnings Details
2/29/2016Q4$0.02($0.12)$19.98 million$14.10 millionViewListenView Earnings Details
11/9/2015Q315($0.02)($0.05)$14.93 million$14.40 millionViewListenView Earnings Details
8/4/2015Q215($0.10)($0.05)$11.84 million$12.96 millionViewListenView Earnings Details
5/7/2015Q414($0.10)($0.07)$13.20 million$13.90 millionViewN/AView Earnings Details
2/26/2015Q4($0.10)($0.14)$13.51 million$14.40 millionViewN/AView Earnings Details
11/10/2014Q314($0.10)($0.10)$13.40 million$13.70 millionViewN/AView Earnings Details
7/31/2014Q2($0.13)($0.08)$13.45 million$13.00 millionViewN/AView Earnings Details
5/12/2014Q1($0.14)($0.20)$14.22 million$13.00 millionViewN/AView Earnings Details
2/26/2014($0.28)($0.21)$14.11 million$13.97 millionViewN/AView Earnings Details
11/5/2013Q3 2013($0.22)($0.34)$13.90 million$13.09 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.31)($0.38)$13.58 million$12.98 millionViewN/AView Earnings Details
5/8/2013Q1 2013($0.34)($0.72)$13.11 million$12.34 millionViewN/AView Earnings Details
3/18/2013Q4 2012($0.44)($0.66)ViewN/AView Earnings Details
11/8/2012Q312($0.50)($0.86)$12.57 million$12.70 millionViewN/AView Earnings Details
8/7/2012Q2 2012($0.48)($0.58)ViewN/AView Earnings Details
5/3/2012Q1 2012($0.43)($0.54)ViewN/AView Earnings Details
3/1/2012Q4 2011($0.17)($0.49)ViewN/AView Earnings Details
11/3/2011Q3 2011($0.25)($0.28)ViewN/AView Earnings Details
8/4/2011Q2 2011($0.20)($0.26)ViewN/AView Earnings Details
5/5/2011Q1 2011($0.14)($0.17)ViewN/AView Earnings Details
3/3/2011Q4 2010($0.06)($0.10)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.02)($0.04)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.04)$0.01ViewN/AView Earnings Details
5/5/2010Q1 2010($0.06)($0.02)ViewN/AView Earnings Details
3/10/2010Q4 2009($0.06)($0.03)ViewN/AView Earnings Details
11/4/2009Q3 2009($0.11)($0.11)ViewN/AView Earnings Details
8/10/2009Q2 2009($0.12)ViewN/AView Earnings Details
5/11/2009Q1 2009($0.12)ViewN/AView Earnings Details
3/16/2009Q4 2008($0.22)ViewN/AView Earnings Details
11/13/2008Q3 2008($0.18)ViewN/AView Earnings Details
8/12/2008Q2 2008($0.08)ViewN/AView Earnings Details
5/7/2008Q1 2008($0.09)ViewN/AView Earnings Details
3/6/2008Q4 2007($0.01)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Rockwell Medical (NASDAQ:RMTI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Rockwell Medical (NASDAQ RMTI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 21.21%
Insider Trading History for Rockwell Medical (NASDAQ:RMTI)
Institutional Ownership by Quarter for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ RMTI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2017David S RichmondInsiderSell36$6.53$235.08176,376View SEC Filing  
3/22/2017David S RichmondInsiderBuy37,210$5.84$217,306.40176,412View SEC Filing  
3/16/2017Kenneth L HoltDirectorSell6,000$5.98$35,880.0017,430View SEC Filing  
11/11/2016Kenneth L HoltDirectorSell19,725$5.16$101,781.0032,355View SEC Filing  
11/1/2016Kenneth L HoltDirectorSell1,400$5.92$8,288.0038,355View SEC Filing  
10/21/2016Kenneth L HoltDirectorSell2,533$6.04$15,299.3241,338View SEC Filing  
9/19/2016Kenneth L HoltDirectorSell8,075$6.81$54,990.7546,858View SEC Filing  
8/25/2016Kenneth L HoltDirectorSell9,520$6.37$60,642.4056,048View SEC Filing  
8/16/2016Kenneth L HoltDirectorSell3,692$7.31$26,988.5263,475View SEC Filing  
12/4/2015Ronald D. BoydDirectorSell12,500$10.58$132,250.0032,500View SEC Filing  
8/14/2015Robert L ChioiniCEOBuy4,910$11.96$58,723.60View SEC Filing  
8/13/2015Raymond Dennis PrattVPBuy5,000$11.54$57,700.00View SEC Filing  
8/13/2015Robert L ChioiniCEOBuy5,090$11.51$58,585.90View SEC Filing  
8/27/2012David A HagelsteinMajor ShareholderBuy7,000$8.10$56,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Rockwell Medical (NASDAQ RMTI) News Headlines

Source:
DateHeadline
Investor Alert: Kaplan Fox Announces Investigation Of Rockwell MedicalInvestor Alert: Kaplan Fox Announces Investigation Of Rockwell Medical
www.prnewswire.com - May 24 at 7:31 PM
Rockwell Medical Inc (RMTI) Expected to Announce Earnings of -$0.13 Per ShareRockwell Medical Inc (RMTI) Expected to Announce Earnings of -$0.13 Per Share
www.americanbankingnews.com - May 24 at 7:20 PM
BRIEF-Rockwell Medical Announces CEO TransitionBRIEF-Rockwell Medical Announces CEO Transition
www.reuters.com - May 24 at 5:44 PM
RMTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Rockwell Medical, Inc ...RMTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Rockwell Medical, Inc ...
www.businesswire.com - May 24 at 5:44 PM
Rockwell Medical announces CEO transition; shares ahead 9% premarketRockwell Medical announces CEO transition; shares ahead 9% premarket
seekingalpha.com - May 24 at 5:44 PM
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Rockwell Medical, Inc. InvestorsGlancy Prongay & Murray LLP Announces Investigation on Behalf of Rockwell Medical, Inc. Investors
www.businesswire.com - May 24 at 5:44 PM
BRIEF-Rockwell Medical Says Independent Directors Determined CEO Termination Not EffectiveBRIEF-Rockwell Medical Says Independent Directors Determined CEO Termination Not Effective
www.reuters.com - May 24 at 5:44 PM
Bragar Eagel & Squire, PC is Investigating Rockwell Medical, Inc. (RMTI) on Behalf of Stockholders and Encourages ...Bragar Eagel & Squire, PC is Investigating Rockwell Medical, Inc. (RMTI) on Behalf of Stockholders and Encourages ...
www.businesswire.com - May 24 at 5:44 PM
Company Isn’t Sure If It Fired Its CEOCompany Isn’t Sure If It Fired Its CEO
finance.yahoo.com - May 24 at 5:44 PM
ROCKWELL MEDICAL, INC. INVESTOR ALERT: Girard Gibbs Announces Investigation on Behalf of RMTI InvestorsROCKWELL MEDICAL, INC. INVESTOR ALERT: Girard Gibbs Announces Investigation on Behalf of RMTI Investors
finance.yahoo.com - May 24 at 5:44 PM
Rockwell Medical Issues StatementRockwell Medical Issues Statement
finance.yahoo.com - May 24 at 5:44 PM
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Rockwell Medical, Inc. - RMTIEQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Rockwell Medical, Inc. - RMTI
finance.yahoo.com - May 24 at 5:44 PM
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Rockwell Medical, Inc. InvestorsGlancy Prongay & Murray LLP Announces Investigation on Behalf of Rockwell Medical, Inc. Investors
finance.yahoo.com - May 24 at 5:44 PM
Bragar Eagel & Squire, P.C. is Investigating Rockwell Medical, Inc. (RMTI) on Behalf of Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. is Investigating Rockwell Medical, Inc. (RMTI) on Behalf of Stockholders and Encourages Investors to Contact the Firm
finance.yahoo.com - May 24 at 5:44 PM
Nasdaq Scheduled Resumption in Rockwell Medical, Inc.Nasdaq Scheduled Resumption in Rockwell Medical, Inc.
finance.yahoo.com - May 24 at 5:44 PM
RMTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Rockwell Medical, Inc. InvestorsRMTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Rockwell Medical, Inc. Investors
www.bizjournals.com - May 24 at 8:18 AM
RMTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Rockwell Medical, Inc. InvestorsRMTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Rockwell Medical, Inc. Investors
finance.yahoo.com - May 24 at 8:18 AM
Nasdaq Halts Rockwell Medical, Inc.Nasdaq Halts Rockwell Medical, Inc.
finance.yahoo.com - May 23 at 5:37 PM
Blood Cleaning Cos Ousted CEO Denies Exit in Filing FaceoffBlood Cleaning Co's Ousted CEO Denies Exit in Filing Faceoff
finance.yahoo.com - May 23 at 5:37 PM
Rockwell Medical CEO Issues Press ReleaseRockwell Medical CEO Issues Press Release
finance.yahoo.com - May 23 at 5:37 PM
Rockwell Medical Announces CEO TransitionRockwell Medical Announces CEO Transition
finance.yahoo.com - May 23 at 8:17 AM
Rockwell Medical (RMTI) Cut to Sell at Zacks Investment ResearchRockwell Medical (RMTI) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - May 17 at 4:19 PM
Stock Traders Buy High Volume of Put Options on Rockwell Medical (RMTI)Stock Traders Buy High Volume of Put Options on Rockwell Medical (RMTI)
www.americanbankingnews.com - May 15 at 6:48 AM
Implied Volatility Surging for Rockwell Medical (RMTI) Stock OptionsImplied Volatility Surging for Rockwell Medical (RMTI) Stock Options
www.zacks.com - May 14 at 8:24 AM
Comparing Rockwell Medical (RMTI) and NxStage (NXTM)Comparing Rockwell Medical (RMTI) and NxStage (NXTM)
www.americanbankingnews.com - May 12 at 5:17 AM
Rockwell Medical (RMTI) Posts  Earnings ResultsRockwell Medical (RMTI) Posts Earnings Results
www.americanbankingnews.com - May 11 at 4:54 PM
Rockwell Medicals (RMTI) CEO Rob Chioini on Q1 2018 Results - Earnings Call TranscriptRockwell Medical's (RMTI) CEO Rob Chioini on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 8:22 AM
Edited Transcript of RMTI earnings conference call or presentation 10-May-18 8:30pm GMTEdited Transcript of RMTI earnings conference call or presentation 10-May-18 8:30pm GMT
finance.yahoo.com - May 11 at 8:22 AM
Rockwell Medical Reports First Quarter 2018 ResultsRockwell Medical Reports First Quarter 2018 Results
finance.yahoo.com - May 10 at 5:59 PM
Rockwell Medical: 1Q Earnings SnapshotRockwell Medical: 1Q Earnings Snapshot
finance.yahoo.com - May 10 at 5:59 PM
3 Things In Biotech, May 9: New AML Therapy Imminent? AVEO Hedges, Rockwell Boosts Iron3 Things In Biotech, May 9: New AML Therapy Imminent? AVEO Hedges, Rockwell Boosts Iron
seekingalpha.com - May 10 at 8:20 AM
Rockwell Medical Update on Calcitriol New Manufacturing Submission to FDARockwell Medical Update on Calcitriol New Manufacturing Submission to FDA
finance.yahoo.com - May 8 at 5:41 PM
Rockwell Medical (RMTI) Expected to Post Earnings of -$0.13 Per ShareRockwell Medical (RMTI) Expected to Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - May 7 at 11:22 AM
Rockwell Medical Schedules First Quarter 2018 Earnings CallRockwell Medical Schedules First Quarter 2018 Earnings Call
feeds.benzinga.com - May 2 at 11:58 AM
Rockwell Medical (RMTI) Scheduled to Post Quarterly Earnings on MondayRockwell Medical (RMTI) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - April 30 at 9:57 AM
 Analysts Expect Rockwell Medical Inc (RMTI) to Post -$0.13 EPS Analysts Expect Rockwell Medical Inc (RMTI) to Post -$0.13 EPS
www.americanbankingnews.com - April 20 at 9:18 AM
Rockwell Medical (RMTI) Upgraded to "Sell" at BidaskClubRockwell Medical (RMTI) Upgraded to "Sell" at BidaskClub
www.americanbankingnews.com - April 10 at 7:19 PM
Active-Investors: Blog Exposure - Impax Launched a Generic Version of Estrace(R) CreamActive-Investors: Blog Exposure - Impax Launched a Generic Version of Estrace(R) Cream
www.finanznachrichten.de - April 10 at 5:31 PM
Does Rockwell Medical Inc (NASDAQ:RMTI) Go Up With The Market?Does Rockwell Medical Inc (NASDAQ:RMTI) Go Up With The Market?
finance.yahoo.com - April 10 at 5:31 PM
Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical MeetingsRockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings
globenewswire.com - April 7 at 4:34 PM
Rockwell Medical (RMTI) Lifted to "Buy" at Zacks Investment ResearchRockwell Medical (RMTI) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 5 at 4:38 PM
Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical MeetingsRockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings
finance.yahoo.com - April 5 at 10:08 AM
Zacks: Brokerages Anticipate Rockwell Medical Inc (RMTI) to Announce -$0.13 Earnings Per ShareZacks: Brokerages Anticipate Rockwell Medical Inc (RMTI) to Announce -$0.13 Earnings Per Share
www.americanbankingnews.com - April 3 at 11:33 AM
Rockwell Medical Sees Unusually Large Options Volume (RMTI)Rockwell Medical Sees Unusually Large Options Volume (RMTI)
www.americanbankingnews.com - March 28 at 6:44 AM
Rockwell Medical (RMTI) Stock Rating Lowered by BidaskClubRockwell Medical (RMTI) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - March 27 at 2:54 PM
Rockwell Medical (RMTI) & Edap Tms (EDAP) Financial SurveyRockwell Medical (RMTI) & Edap Tms (EDAP) Financial Survey
www.americanbankingnews.com - March 22 at 11:12 PM
Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology - GlobeNewswire (press release)Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology - GlobeNewswire (press release)
globenewswire.com - March 21 at 8:44 AM
Wired News – Pfizer Signs Collaboration Deal with BioDuro to Develop Shelf-Stable Fluorosulfation ReagentWired News – Pfizer Signs Collaboration Deal with BioDuro to Develop Shelf-Stable Fluorosulfation Reagent
finance.yahoo.com - March 21 at 8:44 AM
Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of NephrologyRockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology
finance.yahoo.com - March 20 at 5:19 PM
Rockwell Medical (RMTI) Raised to "Hold" at BidaskClubRockwell Medical (RMTI) Raised to "Hold" at BidaskClub
www.americanbankingnews.com - March 18 at 4:58 PM

SEC Filings

Rockwell Medical (NASDAQ:RMTI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Rockwell Medical (NASDAQ:RMTI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Rockwell Medical (NASDAQ RMTI) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.